[Attention-deficit/hyperactivity disorder and substance abuse. Scientific evidence].
Terán Prieto A.
Medicina (B Aires). 2020;80 Suppl 2:76-79.
Cannabinoid hyperemesis syndrome.
Valdivielso Cortázar E, Ucha Abal P, Alonso Aguirre P.
Rev Esp Enferm Dig. 2018 May;110(5):334-335. doi: 10.17235/reed.2018.5430/2017.
Cocaine psychosis.
Baker FM.
J Natl Med Assoc. 1989 Sep;81(9):987, 990, 993-6, passim.
Chlormethiazole abuse.
Gregg E, Akhter I.
Br J Psychiatry. 1979 Jun;134:627-9. doi: 10.1192/bjp.134.6.627.
Do-Do abuse.
Loosmore S, Armstrong D.
Br J Psychiatry. 1990 Aug;157:278-81. doi: 10.1192/bjp.157.2.278.
[Ecstasy toxicity].
Reingardiene D.
Medicina (Kaunas). 2006;42(6):519-23.
'Loads' alert.
Khajawall AM, Sramek JJ Jr, Simpson GM.
West J Med. 1982 Aug;137(2):166-8.
Gamma-hydroxybutyrate abuse: pharmacology and poisoning and withdrawal management.
Marinelli E, Beck R, Malvasi A, Lo Faro AF, Zaami S.
Arh Hig Rada Toksikol. 2020 Mar 1;71(1):19-26. doi: 10.2478/aiht-2020-71-3314.
[Substance abuse and cardiovascular risk: cocaine].
Ciccirillo F, Abrignani MG, Grosseto D, Amico AF, Cocozza S, Gabriele M, Morici N, Santucci A, Boschini A, Giallauria F, Caldarola P, Gulizia MM, Gabrielli D, Colivicchi F.
G Ital Cardiol (Rome). 2022 Jun;23(6):444-453. doi: 10.1714/3810.37941.
Acute Methylenedioxypyrovalerone Toxicity.
Froberg BA, Levine M, Beuhler MC, Judge BS, Moore PW, Engebretsen KM, Mckeown NJ, Rosenbaum CD, Young AC, Rusyniak DE; ACMT Toxicology Investigators Consortium (ToxIC).
J Med Toxicol. 2015 Jun;11(2):185-94. doi: 10.1007/s13181-014-0446-8.
